Statin use and risk of hepatocellular carcinoma in a U.S. population

PURPOSE: Statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) are medications widely prescribed to reduce cholesterol levels. Observational studies in high-risk populations, mostly in Asia, have suggested that statins are associated with a reduced risk of hepatocellular carcinoma (HC...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: McGlynn, Katherine A., Divine, George W., Sahasrabuddhe, Vikrant V., Engel, Lawrence S., VanSlooten, Ashley, Wells, Karen, Yood, Marianne Ulcickas, Alford, Sharon Hensley
Formato: Artigo
Idioma:Inglês
Publicado: 2014
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4188715/
https://ncbi.nlm.nih.gov/pubmed/25113938
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canep.2014.06.009
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares